What Latinaba does

Latinaba (operating as LatinaBA or LBA) is a privately held Contract Research Organization founded in 2009 and headquartered in Buenos Aires, Argentina, with business development offices in Coral Gables, Florida, and country operations offices in Brazil and Chile. The company delivers clinical research services to pharmaceutical and biotech sponsors conducting trials across 15 Latin American countries, operating with a headcount of 11-50 employees. Latinaba provides end-to-end clinical trial execution across Phase I-IV studies, covering site identification and monitoring, regulatory affairs, safety surveillance, medical writing, and trial oversight, with experience spanning 35 therapeutic areas including vaccines, infectious diseases, oncology, cardiovascular, and neurology. Since inception, the company has reported 135 completed projects served across 93 distinct sponsors.

The company's service portfolio is organized into core modules covering Clinical Operations & Project Management, Regulatory Affairs, Medical Devices Research, Real World Evidence studies, Medical Scientific Services, MSL Services, Clinical Trial Oversight, Resourcing Services (including a rent-a-monitor program), CRO and Sponsor Oversight, Quality Programs and Dedicated Services, and Consulting. Latinaba holds ISO certification, signals compliance with ICH-GCP and local regulatory requirements, and combines clinical and epidemiological trial capabilities. Leadership includes CEO Mariano Zarzecki (joined 2016 as COO, became CEO), CFO Cecilia Vidart (joined 2010), Country Manager Brazil Joyce Marinho (founding member of acquired Medicamenta), and Country Manager Chile Alejandro Bisquertt Zavala.

Latinaba generates revenue through professional services contracts on a quote-based pricing model tailored to individual study scope, phase, and geographic coverage. The company distributes services via direct enterprise field sales targeting pharma and biotech sponsors, supported by a US-based business development office and a LinkedIn corporate presence. The 2013 acquisition of Brazilian CRO Medicamenta established Brazil operations, and in January 2025 Latinaba entered a strategic partnership with Belgian CRO P95 BV to enhance vaccine and infectious disease trial capabilities and extend geographic reach across Latin America.

Name

Latinaba

Legal name

LatinaBA

Website

https://latinaba.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Latinaba is a private Contract Research Organization founded in 2009 that provides clinical trial services—including site management, regulatory affairs, monitoring, and medical writing—to pharmaceutical and biotech sponsors across 15 Latin American countries.

Ownership category

akta.pro rank

Product category

Contract Research Organization Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Contract research organization
• Clinical trial services
• Clinical research operations
• Regulatory affairs services
• Real world evidence research

Headquarters

HQ city

Coral Gables

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Research Services: Latinaba generates revenue by providing contract clinical research services to pharmaceutical and biotech sponsors. Services include clinical operations, project management, regulatory affairs, site identification, monitoring, safety surveillance, medical writing, and trial oversight across all phases of clinical development.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Latinaba is a regional Contract Research Organization (CRO) that provides contract clinical research services to pharmaceutical and biotech sponsors conducting trials in Latin America. Its offerings span clinical operations and project management, site identification, regulatory affairs, monitoring, safety surveillance, medical writing, real-world evidence studies, MSL services, and trial oversight, covering Phase I-IV studies and pharmacokinetics across 15 countries.

Product overview

Latinaba is a regional Contract Research Organization (CRO) offering a unified suite of clinical research services for pharmaceutical and biotech sponsors conducting trials in Latin America. The company operates through an integrated platform of service modules that span the full clinical development lifecycle: Clinical Operations & Project Management, Regulatory Affairs, Medical Devices Research, Real World Evidence (RWE) Studies, Medical Scientific Services, MSL Services, Clinical Trial Oversight, Resourcing Services, CRO and Sponsor Oversight, Quality Programs & Dedicated Services, and Consulting. With over 16 years of market experience and offices in Argentina (headquarters), Brazil, and Chile, Latinaba delivers end-to-end clinical trial execution across Phase I to IV studies. The company has completed 135 projects across 15 countries and 93 different sponsors, with expertise spanning 35 therapeutic areas including vaccines, infectious diseases, oncology, cardiovascular, and rare diseases. Recently, Latinaba entered a strategic partnership with P95 BV to enhance vaccine research capabilities in the region.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Operations & Project Management
• Regulatory Affairs
• Medical Devices Research
• Real World Evidence
• Medical Scientific Services
• MSL Services
• Clinical Trial Oversight
• Resourcing Services
• CRO and Sponsor Oversight
• Quality Programs & Dedicated Services
• Consulting

Quantifiable outcome

• 135 completed projects delivered successfully
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• P95 BVcoreStrategic or Co-development Partner · 29 January 2025P95 BV, a Belgian full-service CRO specializing in vaccine development and infectious diseases, has entered a strategic partnership with LatinaBA. The collaboration combines both organizations' strengths to enhance the execution of clinical and epidemiological trials across Latin America, extending their reach to additional countries. Both companies' CEOs highlighted the complementary expertise that will enable better service to vaccine manufacturers and expanded treatment options for patients in Latin America.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO with therapeutic-area specialization and central lab capabilities; comparable in scale and service scope to LatinaBA and a competitor for mid-sized LATAM clinical studies.
• P95 BV: Belgian full-service CRO specializing in vaccine development and infectious diseases; signed a strategic alliance with LatinaBA in January 2025 to jointly deliver vaccine and epidemiological trials in Latin America — direct peer in clinical trial execution for vaccine sponsors.
• Medpace Holdings: Mid-sized global full-service CRO with strong therapeutic-area depth across Phase I–IV studies; comparable to LatinaBA's full-service clinical operations model, though at vastly greater scale and geographic reach.
• Syneos Health: Biopharma solutions organization offering clinical and commercial services globally, including LATAM; comparable full-service clinical operations model across multiple therapeutic areas.

Regional players

• GEMATEC (Argentina): Regional Argentine CRO providing clinical trial management services in Latin America; closely comparable to LatinaBA as a domestic LATAM regional player competing for the same sponsor mandates.

Broad incumbents

• Charles River Laboratories: Provides preclinical and clinical CRO services globally; competes with LatinaBA in the early-phase and clinical research services market and has established LATAM client relationships.
• IQVIA: Largest global CRO with significant LATAM presence, real-world evidence, and technology-enabled trial services; competes head-to-head with LatinaBA for multinational and regional pharma sponsors seeking LATAM execution.
• ICON plc: Global CRO providing clinical research, laboratory, and post-approval services; competes with LatinaBA for LATAM clinical trial work and offers overlapping therapeutic-area coverage and regulatory expertise at a larger scale.
• PPD (Thermo Fisher Scientific): Global CRO acquired by Thermo Fisher in 2021; provides comprehensive clinical development and laboratory services with established LATAM capabilities, directly competing with LatinaBA for regional trial mandates.
• Parexel International: Global CRO offering Phase I–IV clinical services, regulatory consulting, and post-approval evidence; directly competes with LatinaBA on LATAM-based clinical trial execution and biopharma sponsor RFPs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/blanchard-y-asociados

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Latinaba